Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia - Potential clinical significance

Leukemia

Volumn 16, Issue 2, 2002, Pages 170-177

  Inokuchi, K ^a   Yamaguchi, H ^a   Tarusawa, M ^a   Futaki, M ^a   Hanawa, H ^a   Tanosaki, S ^a   Dan, K ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Ba F3; c kit; CML; WBC

Indexed keywords

ADENINE; ASPARAGINE; CYTOSINE; GUANINE; INTERLEUKIN 3; LEUCINE; LYSINE; METHIONINE; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RECOMBINANT STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; THYMINE; TYROSINE;

ADULT; ANIMAL CELL; ARTICLE; BLAST CELL CRISIS; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRAIN; CHRONIC MYELOID LEUKEMIA; CODON; CONTROLLED STUDY; DOSE RESPONSE; EXPRESSION VECTOR; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GROWTH RATE; HAIR ROOT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMOGENESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANIMALS; BLAST CRISIS; BONE MARROW; CELL DIVISION; CELL LINE; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID, AGGRESSIVE-PHASE; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; NEOPLASM PROTEINS; PHOSPHORYLATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-KIT; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION;

EID: 0036166497     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402341     Document Type: Article

References (27)

1. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
2. Chronic myelogenous leukemia: A multivariate analysis of the associations of patient characteristics and therapy with survival
3. Fused transcripts of abl and bcr genes in chronic myelogenous leukemia
4. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia
5. Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts
6. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukemia
7. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature
8. Analysis of breakpoints within the bcr gene and their correlation with clinical course of Philadelphia-positive chronic myelogenous leukemia
9. The biology of chronic myeloid leukemia
10. P190 BCR-ABL chronic myeloid leukemia: The missing link with chronic myelomonocytic leukemia?
11. Expression and function of c-kit in hematopoietic progenitor cells
12. - cells, and the generation of colony-forming cell granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor
13. IL3-dependent mouse clone that express B-220 surface antigen, contain Ig genes in germ-line configration, and generate B lymphocytes in vivo
14. Relation between microsatellite instability and N-ras mutation and duration of disease free survival in patients with acute leukemia
15. p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia
16. Heterogenous expression of bcr-abl fusion mRNA in a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia
17. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-dependent activation of c-kit
18. pEF-BOS, a powerful mammalian expression vector
19. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis
20. CD7 expression on CD34+ cells from chronic myeloid leukemia in chronic phase
21. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
22. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation
23. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal)
24. Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain
25. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
26. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations
27. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines